Page last updated: 2024-09-05

sb 216763 and Fibrosarcoma

sb 216763 has been researched along with Fibrosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abe, K; Aiba, H; Aoki, Y; Araki, Y; Bolidong, D; Domoto, T; Hayashi, K; Higuchi, T; Igarashi, K; Inatani, H; Minamoto, T; Miwa, S; Takeuchi, A; Taniguchi, Y; Tsuchiya, H; Yamamoto, N; Yonezawa, H1

Other Studies

1 other study(ies) available for sb 216763 and Fibrosarcoma

ArticleYear
Glycogen synthase kinase 3β as a potential therapeutic target in synovial sarcoma and fibrosarcoma.
    Cancer science, 2020, Volume: 111, Issue:2

    Topics: Animals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase 4; Fibrosarcoma; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Injections, Intraperitoneal; Maleimides; Mice; Phosphorylation; RNA Interference; Sarcoma, Synovial; Thiazoles; Up-Regulation; Urea; Xenograft Model Antitumor Assays

2020